carvedilol has been researched along with Bright Disease in 1 studies
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol was not found to be as effective as ACEIs and AT1ras in decreasing proteinuria and preserving renal function." | 6.73 | Comparison of higher dose of losartan treatment with losartan plus carvedilol and losartan plus ramipril in patients with glomerulonephritis and proteinuria. ( Akdag, I; Arabul, M; Dilek, K; Ersoy, A; Gullulu, M; Kahvecioglu, S; Yavuz, M; Yurtkuran, M, 2007) |
| "Carvedilol was not found to be as effective as ACEIs and AT1ras in decreasing proteinuria and preserving renal function." | 2.73 | Comparison of higher dose of losartan treatment with losartan plus carvedilol and losartan plus ramipril in patients with glomerulonephritis and proteinuria. ( Akdag, I; Arabul, M; Dilek, K; Ersoy, A; Gullulu, M; Kahvecioglu, S; Yavuz, M; Yurtkuran, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kahvecioglu, S | 1 |
| Akdag, I | 1 |
| Gullulu, M | 1 |
| Arabul, M | 1 |
| Ersoy, A | 1 |
| Dilek, K | 1 |
| Yavuz, M | 1 |
| Yurtkuran, M | 1 |
1 trial available for carvedilol and Bright Disease
| Article | Year |
|---|---|
Comparison of higher dose of losartan treatment with losartan plus carvedilol and losartan plus ramipril in patients with glomerulonephritis and proteinuria.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; C | 2007 |